Wyeth-Ayerst Extends Osteoporosis Genomics Research With Genome Therapeutics | GenomeWeb

NEW YORK, July 16 - Wyeth-Ayerst Laboratories has extended its genomics research collaboration with Genome Therapeutics for at least an additional 18 months, Genome Therapeutics said Monday. 

The joint research project, to develop osteoporosis treatments using targets found by characterizing a gene associated with high bone mass, will now continue until at least December 2002. Genome Therapeutics recently received a milestone payment from Wyeth-Ayerst for its research progress, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.